ANIP vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

ANIP

54.6
AI Score
VS
PCRX Wins

PCRX

54.7
AI Score

Investment Advisor Scores

ANIP

55score
Recommendation
HOLD

PCRX

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ANIP PCRX Winner
Forward P/E 9.1996 9.009 PCRX
PEG Ratio 1.06 11.2121 ANIP
Revenue Growth 20.5% 5.0% ANIP
Earnings Growth 86.1% -30.0% ANIP
Tradestie Score 54.6/100 54.7/100 PCRX
Profit Margin 10.0% 0.7% ANIP
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ANIP 1M: -8.5% · 3M: -2.1% PCRX 1M: +4.5% · 3M: +8.5%

Current Technical Phase

ANIP

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 44

RSI (14): 44.2 · Price: $78.69

PCRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 61

RSI (14): 60.8 · Price: $26.53

Fundamentals Snapshot

Metric ANIP PCRX
Market Cap
Forward P/E 7.4 7.2
Trailing P/E 20.6 207.5
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.8%
Operating Margin 0.2% 0.0%
EPS 3.91 0.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.